PMID: 7029501May 1, 1981Paper

Transient cerebral ischaemic attacks--management and prognosis

Postgraduate Medical Journal
S RodenI Green

Abstract

Fifty patients who had recently had a transient ischaemic attack took part in a double-blind cross-over trial of sulphinpyrazone 200 mg 4 times daily against placebo. Each treatment was given for 4 months. The incidence of recurrences was much greater in the initial 4 months but there was no difference between the 2 treatments. A follow-up of 39 of the patients showed that 2 years later 90% of those who had not had a recurrence during the 8 months had suffered no further neurological events whereas of those who did have a recurrence during the study only 47% had no further neurological events.

References

May 1, 1978·British Medical Bulletin·A G Turpie, J Hirsh
Jul 13, 1978·The New England Journal of Medicine·UNKNOWN Canadian Cooperative Study Group
Mar 1, 1980·Thrombosis Research·J A Jakubowski, N G Ardlie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.